Deals

Musk puts a Tesla-SpaceX merger at 25% within a year

Prediction-market odds put the announcement in early 2027, and the pay agreement Musk signed in 2025 lets a rich deal price vest shares no operating goal has earned. The cost lands on Tesla holders, who also own the deciding vote.

Richard TangRichard Tangthree-minute read
Share
Elon Musk, in a dark suit with an AI Safety Summit lanyard, looking toward the camera at the summit venue.
Elon Musk at the UK government's AI Safety Summit at Bletchley Park in November 2023. He told the New York Times DealBook Summit on November 18, 2026 that Tesla and SpaceX would "probably" be better together.

Elon Musk told the New York Times DealBook Summit on November 18, 2026, that Tesla−2.53% — Tesla, down 2.53 percent today and SpaceX−3.60% — SpaceX, down 3.60 percent today would "probably" be better together, put the odds of a merger within a year at one in four 2, and said he should collect no Tesla stock "simply for merging" 1. He is right about the combination and right about the pay line. The tension is the document he already signed: under his 2025 award, a rich enough exchange ratio can vest shares that no operating goal has earned 1.

The two companies already share chips, models and machines

Five years ago Musk saw no purpose in combining them 1. What changed is technical. SpaceX builds large AI models and sells computing power to customers including the AI company Anthropic$350B — Anthropic, private, latest valuation $350B; Tesla's AI drives its cars and the Optimus robot; and the two design chips together at Terafab, a venture aiming for its first test chip around May or June 2027 1. The overlap has turned the merger question into a question of price.

The market puts the announcement in early 2027

On Kalshi, a prediction market where traders buy contracts on whether events happen, the December contract trades at 23.5%, almost exactly Musk's own number 2. Every maturity from March 2027 onward clears 60%, and CNBC reported the pre-March contract jumping to 62% from 27% in the week before the summit 3. Set against company talk of an announcement in December or early 2027 1, the curve puts the question to shareholders in the first quarter.

Kalshi odds rise from 23.5% in December to 60.5% by March 2027

20%40%60%80%100%by Dec 31, 2026by Feb 1, 2027by Mar 1, 2027by Jul 1, 2027by Jan 1, 2028Musk's own one in four83%First maturity above 60%
Data
Kalshi implied odds
by Dec 31, 202623.5%
by Feb 1, 202744%
by Mar 1, 202760.5%
by Jul 1, 202771.5%
by Jan 1, 202883%
Kalshi contract prices for 'When will Tesla and SpaceX merge?', as of November 18, 2026, in percent. Each point is the implied probability of a merger by that date. Source: Crypto Briefing.2

A deal price can vest shares performance has not earned

The 2025 CEO Performance Award, approved by shareholders on November 6, 2025 7, covers 423.7 million performance shares in 12 tranches 1. Each tranche requires Tesla to hit an operating goal and a valuation target, rising to $8.5 trillion 1.

A change in control vests earned shares, and the valuation test uses whichever is higher, Tesla's last close or the price holders receive in the deal, so a rich price can unlock tranches Tesla's operations have not earned 1. We mapped these mechanics on October 19, when the proxy paved a merger that pays Musk on deal price alone: he can decline payment for merging and still collect on the merger's price.

The vote is the bottleneck, and Tesla holders own it

Nothing is signed: no agreement, no exchange ratio, no timetable 4. Approval needs yes votes from half of Tesla's shares, and shares not voted count as no 5. Musk controls about a fifth of the vote, so retail holders decide whether it clears 5, and his own vote, he said, must account for whether terms make financial sense for other SpaceX investors 1. Texas Attorney General-elect Nathan Johnson has promised "tremendous scrutiny" 3, the review we reported on November 13, along with the premium Tesla holders would fund. Tesla's December 3 annual meeting carries no merger vote 6.

Tesla holders would own a smaller slice of a bigger company

SpaceX, at about $1.9 trillion the larger company, would be the acquirer 6. Its stock trades 6% above its June IPO price 1; Tesla's is down 15% this year 1. In the exchange a Tesla holder's whole claim becomes a minority stake in the combination, and the ratio decides how much value that stake keeps 4. The combination may make sense; the award still lets a deal price vest shares no operating goal has earned, and Tesla's holders are the ones who fund it. The quarter to watch is the first of 2027 4.

Get Deals by email, free

The acquisitions, rounds and contracts that move AI money. In our daily email, every weekday.

Loading SPCX

Reader comments

0 comments

    Deals

    Salesforce agreed to pay $47.50 a share for Braze, whose SEC-filed FAQ leaves renewal terms undecided

    Three weeks after Salesforce agreed to buy Braze for $5.66 billion, the seller's own SEC-filed sales script promises enterprise buyers nothing beyond today's contracts while its account teams push multi-year renewals. For BRZE holders the stock is now a claim on $47.50 in cash, and the deal documents price the wait.

    Deals

    Sacramento votes to renew Axon for $17.7 million and bar AI training on city camera data

    The renewal makes Sacramento own its camera data, opt out of Axon's AI training and bar default sharing with federal agencies. Spread across renewals, those terms reach the data advantage beneath the software Axon's beaten-down stock now leans on.

    Deals

    Merck buys AI drug designs from Isomorphic Labs two days after its $5 billion round

    MSD, Merck & Co. (NYSE: MRK) outside the United States and Canada, carries the clinical and commercial risk and pays an undisclosed upfront, milestones and tiered royalties, while Isomorphic Labs holds a new option to co-fund trials for elevated royalties. Two days after the largest life-science venture round ever, the deal hands Alphabet's (Nasdaq: GOOGL) AI drug spinout its fourth Big Pharma payer before any candidate has entered a human trial.

    Deals

    AMD closed Taalas at $2.9 billion, with $1.4 billion riding on undisclosed milestones

    AMD's completion release named no price; the quarterly filing that carries the terms makes up to $1.4 billion of the $2.9 billion contingent on conditions the company has not disclosed. It is the second AI acquisition in a fortnight, about $11.1 billion combined, by a stock trading above 100 times trailing earnings.

    Deals

    Cognizant won Network Rail's seven-year data center contract 28% under the buyer's own estimate

    The seven-year data-center award hands Cognizant volume in a weak market, but the buyer's own tender estimate shows a large UK public-sector deal clearing about 28% below budget, and the award notice offers no explanation.

    Deals

    Anthropic IPO nears $500 billion in orders before Nasdaq debut

    Anthropic closed its order books on Tuesday with roughly $400 billion of institutional interest and nearly $100 billion of retail interest, about seven times the shares on offer, and is guiding pricing above its $70–$78 range ahead of Thursday's Nasdaq debut under ANT. The final price lands after the US close tonight, and the money it moves reaches from IPO allocators to the chip and cloud suppliers holding guaranteed Anthropic contracts.

    Subscribe to TheInference for free